Dean Investment Associates, LLC Pfizer Inc Transaction History

Dean Investment Associates, LLC

$726 Million
Q3 2024

A detailed history of Dean Investment Associates, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Dean Investment Associates, LLC holds 131,833 shares of PFE stock, worth $3.5 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

131,833

Previous 139,451 5.46%

Holding current value

$3.5 Million

Previous $3.9 Million 2.2%

% of portfolio

0.53%

Previous 0.56%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$27.7 - $31.39 $211,018 - $239,129	-7,618 Reduced 5.46%	131,833 $3.82 Million
Q2 2024 Aug 13, 2024	SELL	$25.26 - $29.6 $136,732 - $160,224	-5,413 Reduced 3.74%	139,451 $3.9 Million
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $29,980 - $34,427	-1,158 Reduced 0.79%	144,864 $4.02 Million
Q4 2023 Feb 09, 2024	SELL	$26.13 - $33.94 $200,887 - $260,930	-7,688 Reduced 5.0%	146,022 $4.2 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $506,316 - $591,832	15,778 Added 11.44%	153,710 $5.1 Million
Q2 2023 Aug 07, 2023	BUY	$36.12 - $41.79 $148,453 - $171,756	4,110 Added 3.07%	137,932 $5.06 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $580,805 - $756,123	14,745 Added 12.38%	133,822 $5.46 Million
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $62,291 - $81,314	-1,492 Reduced 1.24%	119,077 $6.1 Million
Q3 2022 Nov 09, 2022	BUY	$43.76 - $53.42 $97,234 - $118,699	2,222 Added 1.88%	120,569 $5.28 Million
Q2 2022 Aug 18, 2022	SELL	$46.53 - $55.17 $92,082 - $109,181	-1,979 Reduced 1.64%	118,347 $6.21 Million
Q1 2022 May 11, 2022	SELL	$45.75 - $56.69 $44,286 - $54,875	-968 Reduced 0.8%	120,326 $6.23 Million
Q4 2021 Feb 10, 2022	SELL	$41.32 - $61.25 $6,983 - $10,351	-169 Reduced 0.14%	121,294 $7.16 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $16,092 - $20,672	-410 Reduced 0.34%	121,463 $5.22 Million
Q2 2021 Aug 11, 2021	BUY	$35.91 - $40.68 $884,032 - $1 Million	24,618 Added 25.31%	121,873 $4.77 Million
Q1 2021 May 04, 2021	SELL	$33.49 - $37.77 $68,353 - $77,088	-2,041 Reduced 2.06%	97,255 $3.52 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $117,078 - $148,874	-3,498 Reduced 3.4%	99,296 $3.66 Million
Q3 2020 Nov 06, 2020	SELL	$31.75 - $37.25 $60,610 - $71,110	-1,909 Reduced 1.82%	102,794 $3.77 Million
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $97,920 - $118,791	3,251 Added 3.2%	104,703 $3.42 Million
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $57,898 - $82,724	-2,142 Reduced 2.07%	101,452 $3.31 Million
Q4 2019 Feb 12, 2020	SELL	$32.92 - $37.36 $1.41 Million - $1.61 Million	-42,962 Reduced 29.31%	103,594 $4.06 Million
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $214,628 - $278,310	6,606 Added 4.72%	146,556 $5.27 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $295 - $332	-8 Reduced 0.01%	139,950 $6.06 Million
Q1 2019 May 08, 2019	SELL	$37.5 - $41.2 $3,187 - $3,502	-85 Reduced 0.06%	139,958 $5.94 Million
Q4 2018 Feb 06, 2019	BUY	$38.47 - $43.86 $114,756 - $130,834	2,983 Added 2.18%	140,043 $6.11 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $1.36 Million - $1.65 Million	-39,409 Reduced 22.33%	137,060 $6.04 Million
Q2 2018 Aug 08, 2018	SELL	$32.98 - $35.16 $140,692 - $149,992	-4,266 Reduced 2.36%	176,469 $6.4 Million
Q1 2018 May 09, 2018	SELL	$31.91 - $37.02 $137,819 - $159,889	-4,319 Reduced 2.33%	180,735 $6.41 Million
Q4 2017 Feb 05, 2018	BUY	$33.26 - $35.29 $43,903 - $46,582	1,320 Added 0.72%	185,054 $6.7 Million
Q3 2017 Nov 15, 2017	BUY	$31.0 - $34.15 $5.7 Million - $6.27 Million	183,734	183,734 $6.56 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dean Investment Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dean Investment Associates, LLC with notifications on news.

Account

Dean Investment Associates, LLC Pfizer Inc Transaction History